In Britain they just released a study on trans youth.
Most teens who start puberty suppression continue gender-affirming care, study finds
NPR
By Laurel Wamsley
October 26, 2022
A large majority of transgender adolescents who received puberty suppression treatment went on to continue gender-affirming treatment, a new study from the Netherlands has found.The study, published in The Lancet, used data that included people who visited the gender identity clinic of Amsterdam UMC, a leading medical center in the Dutch capital, for gender dysphoria. (Gender dysphoria refers to psychological distress that results from an incongruence between one's sex assigned at birth and one's gender identity.)
Researchers found that a whopping 98% of people who had started gender-affirming medical treatment in adolescence continued to use gender-affirming hormones at follow-up. The finding is significant because of ongoing political debates over whether young people should receive gender-affirming treatment, with some opponents arguing that many transgender children and teens will realize later in life that they aren't really trans.
[…]
The study, thought to be the largest of its kind, provides a new data point in the highly charged political debate over the prescribing of puberty blockers or providing gender-affirming medical care to trans youth. Young people seeking transition-related treatment are sometimes told that they are simply going through "a phase" that they'll grow out of.
Does anyone think this will change the Republican’s minds?
IntroductionPuberty suppression as a treatment for gender-incongruent minors (aged under 18 years) has been the subject of prolific debate and ethical discussion at times generating a schism among specialists. Puberty suppression is used to lessen the discordance between body and gender identity, and to extend the temporal window for gender clarification.4 Because the use of this intervention for extreme gender incongruence is a fairly recent innovation (this intervention has been used for less than 20 years5), very few empirical studies have been done to examine the clinical utility of puberty-suppression treatments in this group, although there is some promising preliminary evidence. Although reversible,6 concerns have been expressed that these treatments can affect physical development and interfere with the natural trajectory of gender expression. In this Review, we examine the scientific literature on the use of puberty-suppression treatment in transgender minors. We start by providing an overview of child and adolescent gender incongruence and gender dysphoria, and the developmental course of gender-discordant behaviour. We then discuss the historical underpinnings and clinical impetus for delaying puberty in this population, provide a summary of the hypothalamic–pituitary–gonadal axis and puberty-suppression treatment, and examine the available empirical evidence for the ability of these treatments to alleviate the distress common in children and adolescents with a transgender identity. We also consider the implications on cognitive and physical development, and surgical outcome, drawing on evidence from recent studies. In recognition of the rapid increase in referrals to child and adolescent gender clinics worldwide with patients presenting at increasingly younger ages we intend this Review to be a timely synthesis of the available evidence.[…]ConclusionsGender incongruence in children and adolescents is complex, and medical treatment raises several ethical considerations. Clinical decision making has been fostered by research efforts, but there are still substantial knowledge gaps that warrant examination to inform best clinical practice (panel 4). The limited available evidence suggests that puberty suppression, when clearly indicated, is reasonably safe. The few studies that have examined the psychological effects of suppressing puberty, as the first stage before possible future commencement of CSH therapy, have shown benefits. Further research is needed to help identify which patients benefit most, and which are at higher risk of regret, changed wishes, or poorer quality-of-life outcomes. The most appropriate time to start treatment remains to be clarified.
No comments:
Post a Comment